Butyl benzyl phthalate


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000072660 Teratozoospermia PMID:39921026
MESH:D000402 Airway Obstruction PMID:28392331
MESH:D000782 Aneuploidy PMID:30763314
MESH:D001172 Arthritis, Rheumatoid PMID:32308655
MESH:D001249 Asthma PMID:28392331
MESH:D002658 Developmental Disabilities PMID:26108271
MESH:D003440 Croup PMID:32952153
MESH:D006967 Hypersensitivity PMID:33836808
MESH:D007333 Insulin Resistance PMID:32905190
MESH:D009336 Necrosis PMID:22138065
MESH:D009362 Neoplasm Metastasis PMID:22552774; PMID:25081364
MESH:D011041 Poisoning PMID:23220035; PMID:32861021
MESH:D011297 Prenatal Exposure Delayed Effects PMID:21241498; PMID:32518293; PMID:34597818
MESH:D011628 Puberty, Delayed PMID:21241498
MESH:D012818 Signs and Symptoms, Respiratory PMID:33836808
MESH:D013733 Testicular Diseases PMID:28611354; PMID:39921026
MESH:D015430 Weight Gain PMID:28611354; PMID:29029336; PMID:30802670; PMID:31319113; PMID:37743007
MESH:D015674 Mammary Neoplasms, Animal PMID:34428494
MESH:D018149 Glucose Intolerance PMID:32905190
MESH:D047928 Premature Birth PMID:24503621
MESH:D060825 Cognitive Dysfunction PMID:36746855
MESH:D064793 Teratogenesis PMID:34933018

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.